H.C. Wainwright analyst Ananda Ghosh raised the firm’s price target on Structure Therapeutics (GPCR) to $90 from $60 and keeps a Buy rating on the shares. The firm says its key opinion leader feedback ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback